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Abstract Sorcin, a 22 kDa calcium binding protein present in 
abundance in cardiac tissue and in multi-drug resistant cells and 
previously described as a soluble protein, is now shown to undergo 
a calcium-dependent translocation process from the cytosol to 
cellular membranes in both systems. The translocation process 
takes place also in E. coli BL21 cells that express recombinant 
sorcin, r-sorcin, and can be exploited in the purification of the 
protein. Calcium binding to purified r-sorcin occurs at micromo- 
lar concentrations of the metal and is accompanied by a confor- 
mational change that renders the protein soluble in the non-ionic 
detergent Triton X-114. This finding suggests that lipids are the 
target of sorcin on cellular membranes. The possible significance 
of the calcium-dependent translocation of sorcin in the specialized 
functions of sorcin-expressing cells is discussed. 
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1. Introduction 
Sorcin is a 22 kDa Ca 2+ binding protein shown to be most 
abundant in heart by immunoblot analysis with sorcin polyclo- 
nal antibodies, but also present in kidney, brain and skeletal 
muscle [1,2]. The protein was originally isolated from the solu- 
ble fraction of multidrug-resistant cells, i.e. cultured cells se- 
lected for resistance to natural product cancer drugs, such as 
vincristine and adriamycin [3 7]. Direct calcium binding studies 
and in vitro phosphorylation assays have shown that sorcin 
purified from heart and sorcin-overproducing cultured cells 
binds Ca 2+ and is phosphorylated by the protein kinase A 
catalytic subunit [1,5,7,8]. These findings are consistent with the 
presence of two EF-hand calcium binding motifs and two puta- 
tive protein kinase A recognition sites in the C-terminal domain 
of the sorcin sequence [4]. The N-terminal domain of the se- 
quence is rich in glycine, proline and tyrosine residues and is 
homologous to the corresponding domain of the calpain light 
chain where it is involved in heterodimer formation [4]. 
The role of sorcin in multidrug resistance and the biological 
function of the protein in normal cells have not been deter- 
mined. Of interest in this regard is a recent publication about 
grancalcin, a protein with a high degree of sequence similarity 
to sorcin, identified in neutrophils and monocytes. Grancalcin 
displays Ca2+-dependent translocation from the cytosol to the 
granules and plasma membrane of neutrophils, suggestive of a 
specialized effector ole for the protein [9]. The present paper 
reports a similar membrane-translocation property of sorcin in 
both cardiac tissue and multidrug-resistant sorcin-overproduc- 
ing cells. Sorcin expressed in E. coli with the use of a newly 
designed prokaryotic expression vector (pKT7SORCIN) like- 
wise translocates to the E. coli membrane; the process can be 
used to advantage in the purification of the protein. 
2. Materials and methods 
2.1. Preparation of the pKT7SOR CIN vector and expression of r-sorcin 
in E. coli 
Full-length sorcin cDNA, isolated from a colchicine-resistant Chi- 
nese hamster ovary library, was a gift from Dr. Piet Borst from The 
Netherlands Cancer Institute [4]. It was amplified by the polymerase 
chain reaction (PCR) utilizing primers that contained restriction sites 
NcoI and HindIlI and were synthesized by the solid-phase triester 
method. Oligonucleotide primers used for PCR were 5'-GGGAAAC- 
CATGGCGTATCCCGGGCAC-3' (annealing to non-coding strand 
bases +20-38, according to the nucleotide base numbering system in [4]) 
and 5'-GGGAAAGGGAAGCTTTTAGACGGTCATGACACAC- 3'
(annealing to coding strand bases 598-616), at the 5' and 3' termini of 
the translated region of the sorcin cDNA, respectively. The amplifica- 
tion product was digested with restriction enzymes NcoI and HindIII 
(Stratagene, La Jolla, CA) before ligation into the T7 promoter-based 
expression vector kindly provided by Dr. Barry Schweitzer [10]. The 
ligation product, pKT7SORCIN (Fig. 1), was used to transform com- 
petent E. coli BL21(DE3) cells which were plated on bacterial LB agar 
plates containing 0.1 mg/ml ampicillin (Boehringer-Mannheim Corp., 
Indianapolis, IN). Transformants were screened for the proper insert 
by PCR. Agarose lectrophoresis was performed on the PCR product, 
plasmid DNA was isolated, and the sorcin cDNA sequenced before 
recombinant expression for verification of the clone. For growth and 
expression of sorcin, bacteria were inoculated into 10 ml of standard 
2 x TY medium (10 g yeast extract, 16 g tryptone and 5 g NaCI per liter) 
containing 0.1 mg/ml ampicillin for overnight growth at 37°C, then 
transferred to 300 ml of 2 x TY medium with ampicillin and 5 mM 
CaCI> Cells were grown to mid-log phase (A600 nm = 1) before addition 
of isopropyl-fl-D-thiogalactopyranoside (Boehringer-Mannheim Corp., 
Indianapolis, IN) to a final concentration of 1 raM. Sorcin was maxi- 
mally expressed after induction for 30-60 min, although no indications 
of cytotoxicity were apparent after longer periods of growth: routinely, 
a 2.5 h induction period was used. Cells were harvested, washed with 
M9 medium [11], and frozen at -70°C or used immediately. 
*Corresponding author. Fax: (39) (6) 444 0062. 
Abbreviations: r-sorcin, recombinant sorcin; SDS-PAGE, sodium 
dodecyl sulfate polyacrylamide gel electrophoresis; EGTA, ethylene 
glycol bis(fl-aminoethyl ether). 
2.2. Purification of r-sorcin 
Harvested bacteria were suspended in 10 mM Tris-HC1 at pH 7.4, 
10 mM NaC1, 1 mM phenylmethyl sulfonyl fluoride (PMSF), 1 mM 
dithiothreitol (DTT), and 0.050 mg/ml each of leupeptin, aprotinin and 
pepstatin, sonicated, and centrifuged at 16,000 x g for 5 min at 15°C. 
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Fig. 1. Construction of sorcin prokaryotic vector, pKT7SORCIN, ori, 
plasmid origin of replication; Amp R, ampicillin resistance gene; 
rrnBT]T2, transcript terminators; T7o, T7 promoter. 
Recovered pellets were washed repeatedly with sonication buffer; the 
final suspension was brought o 10 ml, was made 5 mM in MgC12 and 
DNase was added (0.2 gig). After 30 min incubation at room tempera- 
ture, the suspension was centrifuged at16,000 x g for 5 min. The recov- 
ered pellet was resuspended in sonication buffer containing 5 mM 
EGTA and centrifuged at16,000 x g for 20 min. The supernatant of this 
centrifugation contains r-sorcin with nucleic acids as the main contam- 
inants. Purification of r-sorcin was achieved by chromatography either 
on a MonoQ FPLC column (Pharmacia, Uppsala, Sweden) or on a 
DEAE-5PW HPLC column (Supelco, Bellefonte, PA) equilibrated with 
10 mM Tris-HC1 buffer. A linear gradient of NaC1 between 0 and 
0.5 M was used to recover -sorcin which elutes at 0.25 M NaC1. 
2.3. Subcellular distribution of sorcin in rabbit heart t&sue and in sorcin 
overproducing multidrug-resistant cultured cells 
Ventricular tissue of white New Zealand rabbits was minced, sus- 
pended in 10 mM HEPES buffer at pH 7.5 containing 250 mM sucrose 
with or without 2 mM EGTA, and lysed with a Polytron homogenizer. 
Suspensions were treated and centrifuged at 650xg, 6,500xg, 
39,700 x g and 50,000 x g essentially as described in [12]. Pelleted and 
supernatant fractions were examined for sorcin content by Western blot 
analysis. Sorcin-overproducing vincristine-resistant Chinese hamster 
lung cells (DC-3F/VCRd-SL) [3-6] were harvested from the monolayer 
culture [6] and suspended in 10 mM Tris buffer at pH 7.4 containing 
0.1 M NaC1, 1 mM PMSF and 1 mM dithiothreitol with 1 mM CaCI 2 
or 2 mM EGTA. Cells were lysed with 10 stokes ofa Dounce homog- 
enizer and suspensions were centrifuged sequentially at 2,000 x g, 
10,000 x g and 100,000 x g. Pellet and supernatant fractions were exam- 
ined for sorcin content by Western blot analysis. 
2.4. Gel electrophores& and immunoblott&g 
Sorcin was detected by Coomassie blue staining after SDS-PAGE on 
15% polyacrylamide g ls [13] and by immunoblot analysis after transfer 
of proteins from gels to nitrocellulose [14]. The polyclonal antibody to 
sorcin and procedures for its use have been described [5]. 
2.5. Partition of r-sorcin & Triton X-114 
The partition of sorcin during phase separation i a solution of the 
non-ionic detergent Triton X-114 was carried out as described by Bor- 
dier [15]. In brief, sorcin at 0.5 1.0 mg/ml, in 200 gil of 10 mM Tris-HCl 
buffer at pH 7.4 plus 150 mM NaC1 and 0.6% Triton X-114, and 
containing either 5 mM CaCI2 or 5 mM EGTA, was layered in a conical 
Eppendorf microcentrifuge tube on 300 gi1 of a solution containing 
10 mM Tris-HC1 buffer at pH 7.4 plus 150 mM NaCI, 0.06% Triton 
X-114 and 6% sucrose. The mixture was incubated for 5 min at 30°C, 
namely above the cloud point of the detergent. The tubes were 
centrifuged at 300 x g for 3 min at 30°C. The detergent phase, found 
as an oily droplet at the bottom of the tube, was clearly separated from 
the aqueous phase. Aliquots of the separate phases were analyzed by 
SDS-PAGE. 
2.6. Fluorescence measurements 
Intrinsic fluorescence was measured ina Jasco FP 770 fluorimeter by 
using excitation wavelengths of 278 and 295 nm and a slit width of 
5 nm. 
3. Results 
3.1. Reversible Cae+-dependent association o f  r-sorcin with 
E. coli membranes 
The hypothesis that sorcin, like grancalcin, associates with 
membranes in a Ca2+-dependent fashion was tested in a model 
system, namely sorcin-expressing E. coli cells, since the highly 
expressed r-sorcin can be easily detected. Fig. 2A shows that 
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Fig. 2. Effect of Ca 2+ and Mg 2+ on the presence of r-sorcin in the supernatant ormembrane fraction of sorcin-expressing E coli BL 21 cells analyzed 
by SDS-PAGE. Ceils lysed by sonication i  10 mM Tris-HC1, pH 7.4, containing contaminating calcium, 10 mM NaC1, 1 mM PMSF, 1 mM DTT 
and 50 gig each of leupeptin, aprotinin and pepstatin. (A) Cell lysate subjected to centrifugation at 16,000 x g for 5 min: supernatant, Si and pellet, 
P~. Pt resuspended twice in sonication buffer containing 5 mM EGTA and centrifuged as above yielding, respectively, S 2 and P2 and S~ and P~. 
(B) Purified sorcin and P2 were mixed in 10 mM Tris-HCl, pH 7.0, plus 0.1 M KC1 and 2 mM EGTA containing CaC12 to yield the indicated free 
Ca 2+ concentrations, or in Tris buffer plus 0.2 M NaCI containing 5 mM MgCI 2. Even lanes, purified sorcin; uneven lanes, membrane fraction. Lanes 
2 and 3, controls without added cations. The first lane on the left shows molecular weight markers (46, 30, 21.5, 14.3, 6.5 and 3.4 kDa). The arrowhead 
indicates orcin. SDS-PAGE was carried out according to [13] with Coomassie blue staining. 
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Fig. 3. Effect of Ca 2+ on the presence of sorcin in the supernatant or membrane fractions of DC-3F/VCd-5L cells. Immunoblot analysis with polyclonal 
antibodies against sorcin. Homogenates of cells lysed in the presence of 1 mM CaC12 or of 2 mM EGTA, respectively, were centrifuged as described 
in section 2, and the pellets and supernatants analysed. 
r-sorcin is associated with the membrane fraction of cells lysed 
in the presence of contaminating Ca 2+ (P1, lane 3) and that most 
of the sorcin is released to the supernatant upon treatment of 
that fraction with EGTA ($2, lane 4; and S~, lane 6). Conversely, 
addition of calcium to the supernatant to yield concentrations 
of the free cation in the micromolar range induces reassociation 
of the soluble protein with the membrane (Fig. 2B). The effect 
of Ca 2÷ is specific since addition of Mg 2+ at millimolar concen- 
trations does not lead to a decrease in the concentration of 
sorcin in the supernatant. 
Having established that r-sorcin is able to translocate to 
E. coli membranes in the presence of calcium, similar experi- 
ments were performed with tissues and cells known to express 
natural sorcin to investigate whether the translocation process 
occurs with sorcin in its natural environment. 
Fig. 4. Effect of Ca 2+ on the solubility of sorcin in the aqueous or 
detergent phase of Triton X-114. Bovine serum albumin, cytochrome 
c oxidase and purified r-sorcin, in buffer containing 5 mM CaC12 or 
5 mM EGTA, were mixed with Triton X-114 and submitted to phase 
separation at 30°C as described in section 2. Aliquots of the aqueous 
and detergent phases were analyzed by SDS-PAGE on 12% poly- 
acrylamide gels. Lanes: 1, albumin; 2, cytochrome e oxidase; 3, r-sorcin 
in the presence of calcium; 4, r-sorcin in the presence of EGTA. Lanes 
a, aqueous phase; lanes b, detergent phase. Bovine serum albumin 
partitions in both the aqueous and detergent phase [15]. 
3.2. CaZ+-dependent membrane association of sorcin in rabbit 
heart and in sorcin-overproducing multidrug-resistant cells 
When heart or DC-3F/VCRd-5L sorcin-overproducing cells 
are lysed in the presence of EGTA, the majority of sorcin is 
found in the supernatant fractions, whereas when lysis takes 
place in the presence of calcium most of the sorcin is associated 
with membrane fractions (Fig. 3). In the case of rabbit heart 
cells, sorcin is detected principally in the 39,700 x g and 
50,000 × g membranes which correspond to the crude and salt- 
extracted sarcoplasmic reticulum (SR) (data not shown). 
3.3. Effect of calcium on the partition of sorcin into Triton X-114 
In order to determine whether the target of sorcin during 
membrane association is the lipid phase or a hydrophilic site, 
the behavior of r-sorcin during phase separation of Triton 
X-114 solutions was investigated. This non-ionic detergent sep- 
arates into an aqueous and a detergent phase above 20°C and 
thus allows one to distinguish ydrophilic from amphiphilic 
membrane proteins which partition differently in the two 
phases [15]. r-Sorcin can be recovered from the aqueous phase 
when phase separation takes place in the presence of 5 mM 
EGTA, but is found in the detergent phase when the buffer 
system contains 5 mM CaC12 (Fig. 4). 
3.4. Ca2+-dependent conformational change in r-sorcin 
At a molecular level the Ca2+-dependent translocation of 
sorcin requires a Ca2+-dependent conformational change in the 
protein. Fig. 5 shows that incremental additions of calcium 
progressively quench the intrinsic fluorescence of purified 
r-sorcin and that the apparent Kd of calcium binding is at 
micromolar concentrations of the cation. As expected, based 
on the specificity of Ca 2+ in inducing the translocation of sorcin, 
Mg 2+ has practically no effect on the intrinsic fluorescence of 
the protein (upper inset to Fig. 5). 
4. Discussion 
Studies directed at understanding the biological role of sorcin 
have been based on the premise that sorcin is a cytosolic, 
soluble protein, as the name implies, i.e. soluble resistance- 
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Fig. 5. Quenching of the r-sorcin intrinsic fluorescence as a function of Ca > concentration. Excitation wavelength: C_) 278 nm, (D) 295 nm; 
temperature, 25°C. Protein concentration, 0.2q).3 mg/ml in 10 mM Tris-HCl containing 2 mM EGTA at pH 7.0. The insets show the fluorescence 
emission spectrum as a function of Ca 2÷ and Mg 2. concentration (excitation at 278 nm, arbitrary units). The continuous line in the upper inset shows 
the spectrum of sorcin in the absence of cations. 
related calcium binding protein. However, the present work 
establishes that sorcin, when Ca2+-bound, translocates to cellu- 
lar and subcellular membranes, uggesting new targets for as- 
sessing sorcin's potential biological role. Ca 2. binding, and 
hence the translocation process, occur in the micromolar Ca 2+ 
concentration range, which is pertinent to many signal 
transduction processes. For example, in the cardiac myocyte, 
where sorcin is expressed, the Ca > concentration changes from 
10 -7 to 10 -5 M during the relaxation-contraction cycle, a range 
which brackets the Kj of Ca 2÷ binding to sorcin and suggests 
a potential translocation of the protein during the contractile 
mechanism. A further means of modulating the membrane as- 
sociation process of sorcin may be provided by its phosphoryl- 
ation, an aspect which will be addressed in future work. 
The association of sorcin with membranes i based on the 
occurrence of a conformational change which accompanies cal- 
cium binding. All EF-hand calcium binding proteins hare the 
latter property [16]. However, sorcin is unusual in that intrinsic 
fluorescence is quenched at saturating Ca >, while in most EF- 
hand proteins calcium binding leads to the enhancement of
fluorescence [17 19]. Calcium binding renders orcin soluble in 
the non-ionic detergent Triton X-114, suggesting that the cal- 
cium-dependent association with membranes results from the 
interaction of sorcin with the hydrophobic lipid component. 
The N-terminal domain of sorcin is most likely involved in this 
interaction. In turn, the possible association of sorcin with a 
specific membrane-bound protein is rendered unlikely by the 
fact that such a protein should be ubiquitously distributed in 
markedly different membranes, like those of E. coli and heart 
cells. Based on the assumption that sorcin interacts with the 
lipid component, and is found in greatest abundance in the 
heart and in the kidney, one may speculate that it may affect 
ionic flux through membranes of sorcin-rich tissues. In the 
heart, the association of sorcin with the SR and its calcium- 
dependent conformational change at micromolar concentra- 
tions of the ion, together raise the possibility that sorcin might 
be involved in Ca > homeostasis. 
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